Загрузка...
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
PURPOSE: We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head and neck carcinoma (LA-HNC). PATIENTS AND METHODS: Patients had stage III to IV carcinoma of the oral cavity, orophar...
Сохранить в:
| Опубликовано в: : | J Clin Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Clinical Oncology
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4239304/ https://ncbi.nlm.nih.gov/pubmed/25366680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.3925 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|